A new treatment option for ulcerative colitis
- PMID: 17597673
A new treatment option for ulcerative colitis
Comment on
-
Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study.Aliment Pharmacol Ther. 2006 Oct 1;24(7):1087-97. doi: 10.1111/j.1365-2036.2006.03082.x. Aliment Pharmacol Ther. 2006. PMID: 16984503 Clinical Trial.